<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04956718</url>
  </required_header>
  <id_info>
    <org_study_id>2021-01132; ks21Sinues</org_study_id>
    <nct_id>NCT04956718</nct_id>
  </id_info>
  <brief_title>Breath Metabolomics of Placebo Effects, a Pilot Study</brief_title>
  <acronym>BMPE</acronym>
  <official_title>Breath Metabolomics of Placebo Effects Via Cold Pressor Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Children's Hospital Basel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Swiss National Science Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Children's Hospital Basel</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to analyze the breath metabolome before and after the administration of a&#xD;
      placebo in an established experimental pain procedure in healthy subjects in order to&#xD;
      investigate placebo effects, and whether they induce any measurable changes at the metabolic&#xD;
      level.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Interrogation of the exhaled breath metabolome will be performed by using an objective method&#xD;
      of measurement for placebo effects in pain analgesia, known as Cold Pressure Test (CPT). CPT&#xD;
      reactions can be measured objectively by blood pressure spikes as well as changes in&#xD;
      continuous heart rate monitoring.To this end, probands will be continuously connected to a&#xD;
      Heartrate &amp; Blood Pressure Monitor. First, baseline exhalation will be assessed. Then, the&#xD;
      CPT is performed according to the 'CPT Guide' with subsequent post-pain exhalations analysis&#xD;
      with or without self-administration of the placebo (NaCl nasal spray). After 15 minutes rest,&#xD;
      probands will be submitted to a second post-pain exhalations set (+/- placebo). The process&#xD;
      is completely non-invasive as the participant just exhales through a commercially available&#xD;
      disposable bacterial/viral filter coupled to the ion source.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2021</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Single centered; national ,randomized, crossover, pilot study</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>participants do not know its a placebo</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in signal intensity of mass-to-charge ratio (m/z) of exhaled metabolites</measure>
    <time_frame>1 hour</time_frame>
    <description>The variable of primary interest is the variation of signal intensity of mass-to-charge ratio (m/z) of exhaled metabolites.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>CPT first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Cold Pressor Test (CPT): apparatus for the task is a tank of water of temperature of 4 °C (+-0.5 °C), with instruction to immerse the hand until too uncomfortable to continue. A maximum time limit per immersion of 3-5 min is applied. Quantitative measurement can then be made of pain threshold (point first perceived as painful) and tolerance time.&#xD;
All 20 participants will undergo two study visits. The order in which they will receive CPT and CPT plus placebo differs, with participants being randomly split into two groups. 10 participants first CPT + placebo and then CPT, and 10 participants vice versa.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPT+placebo first</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Participant will be told and read about the 'pain medication' (= Placebo NaCl Nasal spray). Thereafter participant will self-administer a nasal spray, which is in fact a placebo nasal spray containing NaCl solution and Cold Pressor Test (CPT) is performed.&#xD;
All 20 participants will undergo two study visits. The order in which they will receive CPT and CPT plus placebo differs, with participants being randomly split into two groups. 10 participants first CPT + placebo and then CPT, and 10 participants vice versa</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cold Pressor Test (CPT)</intervention_name>
    <description>Cold Pressor Test (CPT): apparatus for the task is a tank of water of temperature of 4 °C (+-0.5 °C), with instruction to immerse the hand until too uncomfortable to continue. A maximum time limit per immersion of 3-5 min is applied. Quantitative measurement can then be made of pain threshold (point first perceived as painful) and tolerance time.</description>
    <arm_group_label>CPT first</arm_group_label>
    <arm_group_label>CPT+placebo first</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo NaCl Nasal spray</intervention_name>
    <description>placebo nasal spray containing NaCl solution</description>
    <arm_group_label>CPT first</arm_group_label>
    <arm_group_label>CPT+placebo first</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy female and male adult volunteers&#xD;
&#xD;
          -  German speaking, or good knowledge of the German language&#xD;
&#xD;
          -  Able to understand the study&#xD;
&#xD;
          -  Able to give informed consent&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Regularly taking medication potentially interfering with pain sensation (analgesics,&#xD;
             antihistamines and calcium and potassium channel blockers)&#xD;
&#xD;
          -  Current pregnancy&#xD;
&#xD;
          -  Daily smokers (as per WHO definition: A daily smoker is someone who smokes any tobacco&#xD;
             product at least once a day.)&#xD;
&#xD;
          -  Neuropathy&#xD;
&#xD;
          -  Chronic pain&#xD;
&#xD;
          -  Neuromuscular or psychiatric disease&#xD;
&#xD;
          -  Known or suspected heart, kidney or liver disease&#xD;
&#xD;
          -  Hypertension (Systolic (mmHg) &gt;130, Diastolic (mmHg) &gt;80)&#xD;
&#xD;
          -  History of fainting or seizures&#xD;
&#xD;
          -  History of Frostbite&#xD;
&#xD;
          -  Current medications (psychoactive medication, narcotics, intake of analgesics) or&#xD;
             being currently in psychological or psychiatric treatment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pablo Sinues, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitäts-Kinderspital beider Basel (UKBB)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mélina Richard</last_name>
    <phone>+41 61 704 14 11</phone>
    <email>melina.richard@ukbb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pablo Sinues, Prof. Dr.</last_name>
    <phone>+41 61 704 29 49</phone>
    <email>pablo.sinues@ukbb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitäts-Kinderspital beider Basel (UKBB)</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mélina D. Richard</last_name>
      <phone>+41 61 704 14 11</phone>
      <email>melina.richard@ukbb.ch</email>
    </contact>
    <investigator>
      <last_name>Pablo Sinues, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jens Gaab, Prof. Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 30, 2021</study_first_submitted>
  <study_first_submitted_qc>June 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 9, 2021</study_first_posted>
  <last_update_submitted>October 25, 2021</last_update_submitted>
  <last_update_submitted_qc>October 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pain</keyword>
  <keyword>placebo effects</keyword>
  <keyword>analgesia</keyword>
  <keyword>placebo analgesia</keyword>
  <keyword>cold pressor test</keyword>
  <keyword>breath metabolomics</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

